News

STANDEX REPORTS FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS
  • In Q3 FY26, Sales Increased 8.1% YOY to $224.6 Million; New Products Sales Grew ~40% and Sales into Fast Growth Markets Contributed >30% of Total Sales
  • In Q3 FY26, Sales Increased 6.5% YOY Organically; Electronics Increased 6.8% YOY Organically
  • Book to Bill of 1.05; Electronics Book to Bill of 1.14
  • Q3 FY26 GAAP Operating Margin of 40.4%; Adjusted Operating Margin of 19.7%, Up 30 bps YOY
  • Continued Portfolio Simplification with Federal Industries’ Divestiture; Leverage Ratio Reduced to 1.9x
  • Expect ~$100 Million of Incremental Sales in FY26 After Federal Divestiture; Fast Growth Market Sales to Grow ~45% to ~$270 Million; Plan to Release >15 New Products Contributing ~300bps of Growth

SALEM, NH – April 30, 2026Standex International Corporation (NYSE: SXI) today reported financial results for the third quarter of fiscal year 2026 ended March 31, 2026.

 Summary Financial Results - Total

 

 

 

 

 

($M except EPS and Dividends)

3Q26

3Q25

2Q26

 Y/Y

Q/Q

Net Sales

$224.6

$207.8

$221.3

8.1%

1.5%

Operating Income – GAAP

$90.8

$26.3

$35.6

246.0%

155.3%

Operating Income – Adjusted

$44.2

$40.3

$42.2

9.5%

4.8%

Operating Margin % - GAAP

40.4%

12.6%

16.1%

2780 bps

2430 bps

Operating Margin % - Adjusted

19.7%

19.4%

19.0%

30 bps

70 bps

Net Income from Continuing Ops – GAAP

$68.6

$22.8

$20.6

201.3%

232.6%

Net Income from Continuing Ops – Adjusted

$26.7

$23.5

$25.1

13.5%

6.5%

 

 

 

 

 

 

EBITDA

$99.4

$35.7

$45.1

178.7%

120.7%

EBITDA margin

44.3%

17.2%

20.4%

2710 bps

2390 bps

Adjusted EBITDA

$48.4

$45.3

$47.2

6.9%

2.6%

Adjusted EBITDA margin

21.6%

21.8%

21.3%

- 20 bps

30 bps

 

 

 

 

 

 

Diluted EPS – GAAP

$5.56

$1.81

$0.17

207.3%

3170.6%

Diluted EPS – Adjusted

$2.21

$1.95

$2.08

13.5%

6.3%

Dividends per Share

$0.34

$0.32

$0.34

6.3%

0.0%

 

 

 

 

 

 

Free Cash Flow

$6.3

$3.5

$13.0

81.5%

-51.6%

Net Debt to EBITDA

1.9x

3.0x

2.3x

-36.7%

-17.4%

Commenting on the quarter’s results, President and Chief Executive Officer David Dunbar said, “We delivered another quarter with year-on-year organic growth and strong operating performance. Our sales increased 8.1% year-on-year to $224.6 million driven by 8% contribution from new products and more than 30% contribution from sales into fast growth markets. We realized 6.5% organic growth with a book to bill of 1.05. Our Electronics segment grew 6.8% organically with a book to bill of 1.14. We are well positioned to deliver mid-to-high single-digit organic growth again in the fiscal fourth quarter, primarily driven by new product launches, and strong tailwinds in the electrical grid, space, defense and aviation end markets. Sales from fast growth markets totaled approximately $69 million in the fiscal third quarter and are expected to reach approximately $270 million for the full fiscal year 2026.

Adjusted operating margin expanded by 30 basis points year-on-year to 19.7%. We paid down approximately $62 million of debt in the fiscal third quarter, and our net leverage ratio was reduced to 1.9x.

On March 6th, we completed the divestiture of Federal Industries at an enterprise value of approximately $70 million. The divestiture supports continued portfolio simplification and enables us to focus on larger businesses and fast growth end market opportunities. As such, we will now report under the four operating segments of Electronics, Aerospace & Defense (formerly Engineering Technologies), Scientific, and Engraving & Hydraulics.”

Fiscal Fourth Quarter 2026 Outlook

In fiscal fourth quarter 2026, on a year-on-year basis, the Company expects slightly to moderately higher revenue, driven by mid-to-high single digit organic growth from higher sales into fast growth end markets and increased new product sales, partially offset by the impact on revenue from the recently completed divestiture of Federal Industries. The Company expects slightly lower adjusted operating margin as contributions from organic growth and realization of productivity actions are more than offset by growth investments, higher medical costs, and increased variable compensation expenses.

On a sequential basis, the Company expects slightly higher revenue, driven by increased contributions from fast growth end markets and new product sales, and slightly to moderately higher adjusted operating margin due to higher volume and pricing and productivity initiatives, partially offset by growth investments.

Fiscal Year 2026 Outlook

The Company’s prior fiscal year 2026 sales outlook included a full year contribution from Federal Industries. Considering the divestiture of Federal Industries and barring any unforeseen economic, global trade, or tariffs related disruptions, the Company now expects revenue to grow by approximately $100 million in fiscal year 2026, which will continue to be driven by mid-to-high single digit organic growth in Electronics and double-digit organic growth in Aerospace & Defense. The Company remains on course to release over fifteen new products that it expects will contribute approximately 300 bps of incremental growth. Sales from fast growth markets are on track to grow approximately 45% year-on-year and reach approximately $270 million.

Third Quarter Segment Operating Performance

The Engineering Technologies segment has been re-named as the Aerospace & Defense segment. The Company believes this name change will improve understanding of the business and its end markets. The Hydraulics business has been combined with the Engraving business under Engraving & Hydraulics segment. As a result, the Company will now report under the four operating segments of Electronics, Aerospace & Defense, Scientific, and Engraving & Hydraulics.

Electronics (53% of sales; 66% of segment adjusted operating income)

 

3Q26

3Q25

% Change

Electronics ($M)

     

Revenue

119.7

111.3

7.6%

GAAP Operating Income

31.7

25.5

24.3%

GAAP Operating Margin %

26.4

22.9

 

Adjusted Operating Income

35.1

33.2

5.9%

Adjusted Operating Margin %

29.3

29.8

 

Revenue increased approximately $8.4 million or 7.6% year-on-year, reflecting organic growth of 6.8% and a foreign currency benefit of 0.8%. Organic growth was driven by sales into fast growth markets and increased new product sales. Adjusted operating income increased approximately $1.9 million or 5.9% year-on-year due to higher volume, pricing initiatives, and product mix, partially offset by growth investments.

The segment had a book-to-bill ratio of approximately 1.14 in the fiscal third quarter, with orders of approximately $136 million.

In fiscal fourth quarter 2026, on a sequential basis, the Company expects slightly to moderately higher revenue, reflecting higher sales into fast growth end markets and increased new product sales. The Company expects slightly higher adjusted operating margin due to higher revenue, partially offset by continued growth investments.

Aerospace & Defense (16% of sales; 12% of segment adjusted operating income)

 

3Q26

3Q25

% Change

Aerospace & Defense ($M)

 

 

 

Revenue

36.6

27.4

33.7%

GAAP Operating Income

5.8

3.4

70.9%

GAAP Operating Margin %

16.0

12.5

 

Adjusted Operating Income

6.6

5.1

29.4%

Adjusted Operating Margin %

18.0

18.6

 

Revenue increased approximately $9.2 million or 33.7% year-on-year reflecting organic growth of 20.8%, a 12.2% benefit from the McStarlite acquisition, and a foreign currency benefit of 0.7%. Organic growth was primarily driven by increased projects activity in the commercialization of space end market. Adjusted operating income increased approximately $1.5 million or 29.4% year-on-year reflecting higher volume.

In fiscal fourth quarter 2026, on a sequential basis, the Company expects slightly to moderately higher revenue due to growth in new product sales and more favorable project timing, and slightly to moderately higher adjusted operating margin due to higher volume and realization of productivity initiatives.

Scientific (8% of sales; 7% of segment adjusted operating income)

 

3Q26

3Q25

% Change

Scientific ($M)

 

 

 

Revenue

18.0

18.3

-1.7%

GAAP Operating Income

3.7

3.9

-4.8%

GAAP Operating Margin %

20.6

21.3

 

Adjusted Operating Income

3.9

4.1

-4.8%

Adjusted Operating Margin %

21.9

22.6

 

Revenue decreased approximately $0.3 million or 1.7% year-on-year reflecting an organic decline of 1.7% from lower demand at academic and research institutions that were impacted by NIH funding cuts. Adjusted operating income decreased approximately $0.2 million or 4.8% year-on-year due to lower sales.

In fiscal fourth quarter 2026, on a sequential basis, the Company expects slightly higher revenue and similar adjusted operating margin due to product mix.

Engraving & Hydraulics (20% of sales; 12% of segment adjusted operating income)

 

3Q26

3Q25

% Change

Engraving & Hydraulics ($M)

   

 

Revenue

44.8

43.8

2.2%

GAAP Operating Income

6.1

5.0

22.0%

GAAP Operating Margin %

13.6

11.3

 

Adjusted Operating Income

6.4

5.3

20.1%

Adjusted Operating Margin %

14.3

12.2

 

Revenue increased approximately $1.0 million or 2.2% year-on-year reflecting a foreign currency benefit of 4.0%, partially offset by an organic decline of 1.8%. The organic decline was primarily driven by general market weakness for hydraulics cylinders. Engraving services had organic growth of 4.0%, driven by slightly improved demand in North America and Asia. Adjusted operating income increased approximately $1.1 million or 20.1% year-on-year due to higher sales and the realization of previously executed restructuring actions.

In fiscal fourth quarter 2026, on a sequential basis, the Company expects slightly lower revenue and similar to slightly higher adjusted operating margin from realization of productivity initiatives.

Capital Allocation

  • Interest: In fiscal fourth quarter 2026, the Company expects interest expense of approximately $6.8 to $7.0 million.
  • Share Repurchase: During the fiscal third quarter of 2026, the Company did not repurchase shares. There was approximately $28 million remaining on the Company’s current share repurchase authorization at the end of the fiscal third quarter 2026.
  • Capital Expenditures: In fiscal third quarter 2026, the Company’s capital expenditures were $5.6 million compared to $6.1 million in the fiscal third quarter of 2025. The Company expects fiscal year 2026 capital expenditures between $27 million and $30 million. Capital expenditures were $28.3 million in fiscal year 2025.
  • Dividend: On April 23, 2026, the Company declared a quarterly cash dividend of $0.34 per share, an approximately 6.3% year-on-year increase. The dividend is payable May 22, 2026, to shareholders of record on May 8, 2026.

Balance Sheet and Cash Flow Highlights

  • Net Debt: Standex had net (cash) debt of $369.1 million on March 31, 2026, compared to $470.4 million at the end of fiscal third quarter 2025. Net (cash) debt for the third quarter of 2026 consisted primarily of long-term debt of $472.8 million and cash and equivalents of $103.7 million.
  • Cash Flow: Net cash provided by continuing operating activities for the three months ended March 31, 2026, was $11.9 million compared to $9.6 million in the prior year’s quarter. Free cash flow after capital expenditures was $6.3 million compared to free cash flow after capital expenditures of $3.5 million in the fiscal third quarter of 2025. 

Conference Call Details

Standex will host a conference call for investors tomorrow, May 1, 2026, at 8:30 a.m. ET. On the call, David Dunbar, President and CEO, and Ademir Sarcevic, CFO, will review the Company’s financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the “Investors” section of Standex’s website under the subheading, “Events and Presentations,” located at www.standex.com.

A replay of the webcast will also be available on the Company’s website shortly after the conclusion of the presentation online through May 1, 2027. To listen to the teleconference playback, please dial in the U.S. (888) 660-6345 or (646) 517-4150 internationally; the passcode is 06832#. The audio playback via phone will be available through May 8, 2026. The webcast replay can be accessed in the “Investor Relations” section of the Company’s website, located at www.standex.com.

Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles (“GAAP”), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures which exclude the impact of restructuring charges, purchase accounting, amortization from acquired intangible assets, insurance recoveries, discrete tax events, gain or loss on sale of a business unit, acquisition costs, and litigation costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods.  An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect.  Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

About Standex

Standex International Corporation is a multi-industry manufacturer in four broad business segments: Electronics, Aerospace and Defense, Scientific, and Engraving & Hydraulics with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. For additional information, visit the Company's website at http://standex.com/.

Forward-Looking Statements

Statements contained in this Press Release that are not based on historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as should,” “could,” “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue, or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Companys business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the electrical grid, automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; increased costs from acquisitions to improve and coordinate managerial, operational, financial, and administrative systems, including internal controls over financial reporting and  compliance with the Sarbanes-Oxley Act of 2002, and other costs related to such systems in connection with acquired businesses; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; the impact on our operations of any successful cybersecurity attacks; and potential changes to future pension funding requirements. For a more comprehensive discussion of these and other factors, see the “Risk Factors” section of the Company’s most recent annual report on Form 10-K filed with the SEC and available on the Company’s website. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.

Standex International Corporation
Consolidated Statement of Operations
(unaudited)
         
    Three Months Ended   Nine Months Ended
    March 31,   March 31,   March 31,   March 31,
(In thousands, except per share data)   2026     2025   2026     2025
               
Net sales   $ 224,595       207,780    $ 663,346    $ 568,058 
Cost of sales   132,663       125,350     388,749     344,108 
Gross profit   91,932       82,430     274,597       223,950 
               
Selling, general and administrative expenses   48,067       47,564     149,063     130,796 
(Gain) loss on sale of business   (56,837)     -       (56,837)   -   
Restructuring costs   2,989       1,976     9,425     3,982 
Amortization of acquired intangible assets   4,374       4,485     13,350     9,965 
Acquisition related costs   2,513       2,152     3,562     20,392 
               
Income from operations   90,826       26,253     156,034       58,815 
               
Interest expense   7,328       8,363     24,154       14,915 
Other non-operating (income) expense, net   828       309     1,054       1,171 
Total   8,157       8,672     25,208       16,086 
               
Income from continuing operations before income taxes   82,669       17,581     130,826       42,729 
Provision for income taxes   14,037       (5,197)   25,738     475 
Net income from continuing operations   68,632       22,778     105,088       42,254 
               
Income (loss) from discontinued operations, net of tax   (115)     (52)   (94)   (56)
               
Net income     68,517       22,726     104,994       42,198 
Less: net income attributable to redeemable noncontrolling interest   755       846     2,076       1,264 
Less: change of redeemable noncontrolling interest to redemption value   784       -       18,763       -   
Net income attributable to Standex International   $ 66,978    $ 21,880    $ 84,155    $ 40,934 
               
Basic earnings per share:              
Income (loss) from discontinued operations   (0.01)     -       (0.01)     -   
Total income (loss) attributable to Standex International   $ 5.57    $ 1.83    $ 7.00    $ 3.44 
               
Diluted earnings per share:              
Income (loss) from discontinued operations   (0.01)     -       (0.01)     -   
Total income (loss) attributable to Standex International   $ 5.56    $ 1.81    $ 6.99    $ 3.41 
               
Average Shares Outstanding        
   Basic   12,048       11,986       12,033     11,906 
   Diluted   12,062       12,059       12,053     11,997 

 

Standex International Corporation
Condensed Consolidated Balance Sheets
(unaudited)
             
    March 31,      June 30, 
(In thousands)   2026     2025
         
ASSETS        
Current assets:        
  Cash and cash equivalents   $ 103,725      104,542 
  Accounts receivable, net   179,695      172,702 
  Inventories   129,563      129,994 
  Prepaid expenses and other current assets   69,736       73,641 
    Total current assets   482,719       480,879 
         
Property, plant, equipment, net   152,581       160,364 
Intangible assets, net   204,855       225,757 
Goodwill   585,503       610,338 
Deferred tax asset   9,786       11,971 
Operating lease right-of-use asset   45,812       47,998 
Other non-current assets   45,521       29,573 
    Total non-current assets   1,044,058       1,086,001 
         
Total assets   $ 1,526,777    $ 1,566,880 
         
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY        
         
Current liabilities:        
  Accounts payable   $ 77,361       88,001 
  Accrued liabilities   64,180       63,204 
  Income taxes payable   16,864       15,770 
    Total current liabilities   158,405       166,975 
         
Long-term debt   472,841       552,515 
Operating lease long-term liabilities   36,586       40,057 
Accrued pension and other non-current liabilities   60,539     67,743 
    Total non-current liabilities   569,966       660,315 
         
Redeemable non-controlling interest   44,227       27,913 
         
Stockholders' equity:        
  Common stock   41,976     41,976 
  Additional paid-in capital   142,396     136,082 
  Retained earnings   1,198,976     1,126,851 
  Accumulated other comprehensive loss   (198,941)   (164,765)
  Treasury shares   (430,228)   (428,467)
     Total stockholders' equity   754,179       711,677 
         
Total liabilities, redeemable noncontrolling interest and stockholders' equity   $ 1,526,777    $ 1,566,880 

 

Standex International Corporation and Subsidiaries
Statements of Consolidated Cash Flows
(unaudited)
      Nine Months Ended
    March 31,
(In thousands)     2026     2025
             
Cash Flows from Operating Activities        
Net income   $ 104,994       42,198 
Income (loss) from discontinued operations   (94)     (56)
Income from continuing operations     105,088       42,254 
             
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization   29,249       25,310 
Stock-based compensation   6,578       7,878 
Non-cash portion of restructuring charge   575       (401)
(Gain) loss on sale of business   (56,837)     -   
Contributions to defined benefit plans   (5,352)     (6,153)
Net changes in operating assets and liabilities   (29,884)   (32,675)
Net cash provided by operating activities - continuing operations   49,417       36,213 
Net cash provided by (used in) operating activities - discontinued operations   (286)     (42)
Net cash provided by (used in) operating activities   49,131       36,171 
Cash Flows from Investing Activities    
    Capital Expenditures   (19,674)     (19,762)
    Expenditures for acquisitions, net of cash acquired        (477,381)
    Proceeds from the sale of business   68,299       -   
    Other investing activities   (423)     3,800 
Net cash provided by (used in) investing activities   48,202       (493,343)
Cash Flows from Financing Activities        
    Proceeds from borrowings        792,313 
    Payments of debt   (80,000)     (362,109)
    Contingent consideration payment   (330)     -   
    Activity under share-based payment plans   1,775       2,019 
    Purchase of treasury stock   (3,800)     (9,582)
    Distributions to non-controlling interests   (2,324)     -   
    Cash dividends paid   (12,135)     (11,197)
    Other financing activities   -         -   
Net cash provided by (used in) financing activities   (96,814)     411,444 
             
Effect of exchange rate changes on cash   (1,336)     1,335 
             
Net changes in cash and cash equivalents   (817)     (44,393)
Cash and cash equivalents at beginning of year   104,542       154,203 
Cash and cash equivalents at end of period   $ 103,725    $ 109,810 

 

Standex International Corporation
Selected Segment Data
(unaudited)
                         
    Three Months Ended     Nine Months Ended
      March 31,     March 31,
(In thousands)   2026     2025     2026     2025
Net Sales                  
Electronics   $ 119,707    $ 111,283    $ 345,928    $ 284,939 
Aerospace & Defense   36,591       27,375       97,121     70,555 
Scientific   17,979       18,292       56,931     54,462 
Engraving & Hydraulics   44,780       43,815       139,913     132,321 
Other   5,538       7,015       23,453       25,781 
Total   $ 224,595    $ 207,780    $ 663,346    $ 568,058 
                   
Income from operations                  
Electronics   $ 31,656    $ 25,471    $ 89,705    $ 59,918 
Aerospace & Defense   5,841       3,417       13,836     11,120 
Scientific   3,708       3,895       12,874     13,362 
Engraving & Hydraylics   6,138       4,974       20,959     18,178 
Other   762       1,362       4,046       5,214 
Restructuring   (2,989)     (1,976)     (9,425)   (3,982)
Gain (loss) on sale of business   56,837       -         56,837     -   
Acquisition related costs   (2,513)     (2,152)     (3,562)   (20,392)
Corporate   (8,614)     (8,738)     (29,236)     (24,603)
Total   $ 90,826    $ 26,253    $ 156,034    $ 58,815 

 

Standex International Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
(unaudited)
             
    Three Months Ended         Nine Months Ended    
    March 31,         March 31,    
(In thousands, except percentages)   2026     2025   % Change     2026     2025   % Change
Adjusted income from operations and adjusted net income from continuing operations:                                
Net Sales   $ 224,595    $ 207,780    8.1%   $ 663,346    $ 568,058    16.8%
Income from operations, as reported   $ 90,826    $ 26,253    246.0%   $ 156,034    $ 58,815    165.3%
  Income from operations margin   40.4%   12.6%       23.5%   10.4%  
Adjustments:            
  Restructuring charges   2,989     1,976       9,425     3,982   
  Acquisition-related costs   2,513     2,152       3,562     20,392   
  Amortization of acquired intangible assets   4,374     4,485       13,350     9,965   
  Litigation (settlement refund) charge   -       -         100     -     
  (Gain) loss on sale of business   (56,837)   -         (56,837)   -     
  Purchase accounting expenses   331     5,479       2,316     11,676   
Adjusted income from operations   $ 44,196    $ 40,345    9.5%   $ 127,950    $ 104,830    22.1%
  Adjusted income from operations margin   19.7%   19.4%     19.3%   18.5%  
  Interest and other income (expense), net   (8,157)   (8,672)     (25,208)   (16,086)  
  Foreign currency related (gain) loss on acquisition and divestiture activities   -       -         -       554   
  Provision for income taxes   (14,037)   5,197       (25,738)   (475)  
  Discrete and other tax items   -       (9,321)     -       (8,946)  
  Tax impact of above adjustments   5,458     (3,173)     892     (10,314)  
Net income from continuing operations, as adjusted   27,461     24,375       77,896     69,563   
  Less: net income attributable to redeemable noncontrolling interest   1,539     846       20,839     1,264   
  Add back: change of redeemable noncontrolling interest to redemption value per the acquisition agreement   (784)   -         (18,763)   -     
Net income from continuing operations attributable to Standex, as adjusted   $ 26,706    $ 23,530    13.5%   $ 75,820    $ 68,299    11.0%
             
EBITDA and Adjusted EBITDA:                
Net income (loss) from continuing operations, as reported   $ 68,632    $ 22,778    201.3%   $ 105,088    $ 42,254   
  Net income from continuing operations margin     30.6%   11.0%     15.8%   7.4%  
Add back:            
  Provision for income taxes     14,037     (5,197)     25,738     475   
  Interest expense   7,328     8,363       24,154     14,915   
  Depreciation and amortization   9,448     9,744       29,249     25,310   
EBITDA   $ 99,446    $ 35,688    178.7%   $ 184,229    $ 82,954    122.1%
  EBITDA Margin   44.3%   17.2%     27.8%   14.6%  
Adjustments:            
  Restructuring charges   2,989     1,976       9,425     3,982   
  Acquisition-related costs   2,513     2,152       3,562     20,392   
  Litigation (settlement refund) charge   -       -         100     -     
  (Gain) loss on sale of business   (56,837)   -         (56,837)   -     
  Purchase accounting expenses   331     5,479       2,316     11,676   
Adjusted EBITDA   $ 48,441    $ 45,295    6.9%   $ 142,795    $ 119,004    20.0%
  Adjusted EBITDA Margin   21.6%   21.8%     21.5%   20.9%  
             
Free operating cash flow:                
Net cash provided by operating activities - continuing operations, as reported   $ 11,904    $ 9,551      $ 49,417    $ 36,213   
Less: Capital expenditures   (5,590)   (6,072)     (19,674)   (19,762)  
Free cash flow from continuing operations   $ 6,314    $ 3,479      $ 29,743    $ 16,451   

 

Standex International Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
(unaudited)
             
    Three Months Ended         Nine Months Ended    
Adjusted earnings per share from continuing operations     March 31,         March 31,    
    2026     2025   %
Change
    2026     2025   % Change
             
Diluted earnings per share from continuing operations attributable to Standex, as reported   $ 5.56    $ 1.81    207.3%   $ 6.99    $ 3.41    105.0%
Adjustments:            
  Restructuring charges   0.19     0.13       0.59     0.25   
  Acquisition-related costs   0.16     0.14       0.23     1.36   
  Amortization of acquired intangible assets   0.28     0.29       0.84     0.63   
  Litigation (settlement refund) charge   -       -         0.01     -     
  (Gain) loss on sale of business   (4.06)   -         (4.06)   -     
  Foreign currency related (gain) loss on acquisition and divestiture activities   -       -         -       0.04   
  Discrete tax items   -       (0.77)     -       (0.74)  
  Purchase accounting expenses   0.02     0.35       0.15     0.74   
  Change of redeemable noncontrolling interest to redemption value per the acquisition agreement   0.06     -         1.56     -     
Diluted earnings per share from continuing operations attributable to Standex, as adjusted   $ 2.21    $ 1.95    13.5%   $ 6.29    $ 5.69    10.6%
 
For further information: Christopher Howe, Director of Investor Relations, (773) 754-5394, e-mail: InvestorRelations@Standex.com
Sign up for Alerts